Journal
MOLECULAR BIOTECHNOLOGY
Volume 65, Issue 6, Pages 904-912Publisher
SPRINGERNATURE
DOI: 10.1007/s12033-022-00572-3
Keywords
Diabetic retinopathy; Luciferase; Capillary
Ask authors/readers for more resources
Diabetic retinopathy (DR) is a major cause of visual impairment and blindness. This study investigated the involvement of lncRNA SPAG5-AS1 (SPAG5-AS1) in retinal vascular dysfunction under diabetic conditions. The results showed that SPAG5-AS1 attenuates diabetic retinal vascular dysfunction through the miR-1224-5p/IRS-1 axis, suggesting a potential therapeutic strategy for DR.
Diabetic retinopathy (DR) is causal for visual impairment and blindness. The research aimed at whether and how lncRNA SPAG5-AS1 (SPAG5-AS1) is involved in retinal vascular dysfunction under diabetic conditions. After determination of SPAG5-AS1, miR-1224-5p, and IRS-1 expression in high glucose (HG)-treated human retinal microvascular endothelial cells (hRMECs), their respective influences on retinal vascular dysfunction was explored by cell counting kit-8, Transwell, wound-healing assay, and tube formation assay. SPAG5-AS1/miR-1224-5p/IRS-1 interaction was identified through bioinformatics analysis and luciferase reporter gene assays. As tested, SPAG5-AS1 and IRS-1 levels were induced, while miR-1224-5p was enhanced in HG-treated hRMECs. Up-regulating SPAG5-AS1 or downregulating miR-1224-5p could inhibit hRMECs proliferation, migration, and tube formation, and vice versa. SPAG5-AS1 can promote IRS-1 expression by miR-1224-5p, and depletion of IRS-1 was functional for the reversal of up-regulated SPAG5-AS1-modified influences on HG-treated hRMECs. Additionally, in diabetic rats, SPAG5-AS1 can alleviate retinal vascular dysfunction. All in all, SPAG5-AS1 attenuates diabetic retinal vascular dysfunction through miR-1224-5p/IRS-1 axis, providing a potential therapeutic strategy for DR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available